Progentos Funding & Investors
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
progentos.comTotal Amount Raised: $65,000,000
Progentos Funding Rounds
Series A
$65,000,000
Series A Investors
Forbion Capital PartnersMission BioCapitalAlta PartnersDolby Family VenturesLongwood Fund
Funding info provided by Diffbot.